Percutaneous radiofrequency ablation for small primary hepatic cancer
- VernacularTitle:经皮肝穿刺射频热凝治疗原发性小肝癌
- Author:
Tong ZHU
;
Yin SHENG
;
Jun FAN
;
Yin WANG
- Publication Type:Journal Article
- Keywords:
LIVER NEOPLASMS/ther;
RADIOFREQUENCY ABLATION;
PERCUTANEOUS TRANSHEPATIC
- From:
Chinese Journal of General Surgery
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and indications of percutaneous radiofrequency ablation (PRFA) for small primary liver cancer(SPLC). Methods The clinical data of 16 patients with SPLC treated by PRFA were analysed retrospectively. Results The diameter of tumor in all 16 patients were ≤3cm. After PEFA, AFP from postive returned to negative in 93.3% of patients; and BUS and CT showed the tumors shrinking with capsule formation. The 0.5,1,2-year survival rate were 93.8%,100%,100% respectively. Conclusions PRFA for SPLC has advantages such as minitrauma, safe and effective, especiolly suitable to the patients with contrainsications of operation, or the tumor locating to the deep position of liver, or around inferior vena cava, hepatic veins or hepatic porta etc.
